The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo

References

• DvorakHFSengerDRDvorakAMHarveyVSMcDonaghJRegulation of extravascular coagulation by microvascular permeabilityScience1985227105910613975602
   PubMed Web of Science ®Google Scholar
• NeriDCarnemollaBNissimATargeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformNat Biotechnol199715127112759359110
   PubMed Web of Science ®Google Scholar
• YeFWuXJeongEKA peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRIBioconjug Chem2008192300230319053180
   PubMed Web of Science ®Google Scholar
• AbeKShojiMChenJRegulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factorProc Natl Acad Sci U S A1999968663866810411932
   PubMed Web of Science ®Google Scholar
• AhmadSAnsariAATherapeutic roles of heparin anticoagulants in cancer and related disordersMed Chem2011750451721801147
   PubMed Web of Science ®Google Scholar
• SimbergDDuzaTParkJHBiomimetic amplification of nanoparticle homing to tumorsProc Natl Acad Sci U S A200710493293617215365
   PubMed Web of Science ®Google Scholar
• AgemyLSugaharaKNKotamrajuVRNanoparticle-induced vascular blockade in human prostate cancerBlood20101162847285620587786
   PubMed Web of Science ®Google Scholar
• KarmaliPPKotamrajuVRKastantinMTargeting of albumin-embedded paclitaxel nanoparticles to tumorsNanomedicine20095738218829396
   PubMed Web of Science ®Google Scholar
• KruseAMMeenachSAAndersonKWHiltJZSynthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applicationsActa Biomater2014102622262924486913
   PubMed Web of Science ®Google Scholar
• SlingerlandMGuchelaarHJGelderblomHLiposomal drug formulations in cancer therapy: 15 years along the roadDrug Discov Today20121716016621983329
   PubMed Web of Science ®Google Scholar
• YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res199555375237567641188
   PubMed Web of Science ®Google Scholar
• NeedhamDAnyarambhatlaGKongGDewhirstMWA new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft modelCancer Res2000601197120110728674
   PubMed Web of Science ®Google Scholar
• MeersPEnzyme-activated targeting of liposomesAdv Drug Deliv Rev20015326527211744171
   PubMed Web of Science ®Google Scholar
• PedersenPJAdolphSKSubramanianAKLiposomal formulation of retinoids designed for enzyme triggered releaseJ Med Chem2010533782379220405849
   PubMed Web of Science ®Google Scholar
• HatakeyamaHMurataMSatoYThe systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in miceJ Control Release2014173435024511611
   PubMed Web of Science ®Google Scholar
• YubaETajimaNYoshizakiYHaradaAHayashiHKonoKDextran derivative-based pH-sensitive liposomes for cancer immunotherapyBiomaterials2014353091310124406217
   PubMed Web of Science ®Google Scholar
• Alvarez-LorenzoCBrombergLConcheiroALight-sensitive intelligent drug delivery systemsPhotochem Photobiol20098584886019222790
   PubMed Web of Science ®Google Scholar
• SeoHJKimJCLight-sensitive liposomes containing coumarin- proteinoid conjugateJ Nanosci Nanotechnol2012124044405022852345
   PubMed Web of Science ®Google Scholar
• IbsenSBenchimolMSimbergDSchuttCSteinerJEsenerSA novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payloadJ Control Release201115535836621745505
   PubMed Web of Science ®Google Scholar
• SuttonJTRaymondJLVerleyeMCPyne-GeithmanGJHollandCKPulsed ultrasound enhances the delivery of nitric oxide from bubble liposomes to ex vivo porcine carotid tissueInt J Nanomedicine201494671468325336947
   PubMed Web of Science ®Google Scholar
• CoolSKGeersBRoelsSCoupling of drug containing liposomes to microbubbles improves ultrasound triggered drug delivery in miceJ Control Release201317288589324075924
   PubMed Web of Science ®Google Scholar
• KneidlBPellerMWinterGLindnerLHHossannMThermosensitive liposomal drug delivery systems: state of the art reviewInt J Nanomedicine201494387439825258529
   PubMed Web of Science ®Google Scholar
• LiLten HagenTLHaeriAA novel two-step mild hyperthermia for advanced liposomal chemotherapyJ Control Release201417420220824269966
   PubMed Web of Science ®Google Scholar
• IyerAKSinghAGantaSAmijiMMRole of integrated cancer nanomedicine in overcoming drug resistanceAdv Drug Deliv Rev2013651784180223880506
   PubMed Web of Science ®Google Scholar
• LiLten HagenTLSchipperDTriggered content release from optimized stealth thermosensitive liposomes using mild hyperthermiaJ Control Release201014327427920074595
   PubMed Web of Science ®Google Scholar
• ChenQTongSDewhirstMWYuanFTargeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposomeMol Cancer Ther200431311131715486198
   PubMed Web of Science ®Google Scholar
• TagamiTMayJPErnstingMJLiSDA thermosensitive liposome prepared with a Cu2-gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacyJ Control Release201216114214922504351
   PubMed Web of Science ®Google Scholar
• TagamiTErnstingMJLiSDOptimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro systemJ Control Release201115429029721640149
   PubMed Web of Science ®Google Scholar
• AgarwalAMackeyMAEl-SayedMABellamkondaRVRemote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorodsACS Nano201154919492621591812
   PubMed Web of Science ®Google Scholar
• TagamiTErnstingMJLiSDEfficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicinJ Control Release201115230330921338635
   PubMed Web of Science ®Google Scholar
• WeinsteinJNMaginRLYatvinMBZaharkoDSLiposomes and local hyperthermia: selective delivery of methotrexate to heated tumorsScience1979204188191432641
   PubMed Web of Science ®Google Scholar
• YatvinMBWeinsteinJNDennisWHBlumenthalRDesign of liposomes for enhanced local release of drugs by hyperthermiaScience197820212901293364652
   PubMed Web of Science ®Google Scholar
• MillsJKNeedhamDLysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transitionBiochim Biophys Acta20051716779616216216
   PubMed Web of Science ®Google Scholar
• PoonRTBorysNLyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancerExpert Opin Pharmacother20091033334319236203
   PubMed Web of Science ®Google Scholar
• LindnerLHHossannMVogeserMDual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug releaseJ Control Release200812511212018022271
   PubMed Web of Science ®Google Scholar
• LandonCDParkJYNeedhamDDewhirstMWNanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancerOpen Nanomed J20113386423807899
   PubMedGoogle Scholar
• KongGAnyarambhatlaGPetrosWPEfficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug releaseCancer Res2000606950695711156395
   PubMed Web of Science ®Google Scholar
• BannoBIckensteinLMChiuGNThe functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivoJ Pharm Sci2010992295230819902527
   PubMed Web of Science ®Google Scholar
• SmithBLyakhovILoomisKHyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes)J Control Release201115318719421501640
   PubMed Web of Science ®Google Scholar
• NegussieAHMillerJLReddyGDrakeSKWoodBJDreherMRSynthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposomeJ Control Release201014326527320067811
   PubMed Web of Science ®Google Scholar
• YuKFZhangWQLuoLMThe antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluationInt J Nanomedicine201382473248523885174
   PubMed Web of Science ®Google Scholar
• DuRZhongTZhangWQAntitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanomaInt J Nanomedicine201493091310525028548
   PubMed Web of Science ®Google Scholar
• YudinaAde SmetMLepetit-CoifféMUltrasound-mediated intracellular drug delivery using microbubbles and temperature-sensitive liposomesJ Control Release201115544244821689699
   PubMed Web of Science ®Google Scholar
• KonoKOzawaTYoshidaTHighly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specific chemotherapyBiomaterials2010317096710520580431
   PubMed Web of Science ®Google Scholar
• VichaiVKirtikaraKSulforhodamine B colorimetric assay for cytotoxicity screeningNat Protoc200611112111617406391
   PubMed Web of Science ®Google Scholar
• WangSKotamrajuSKonorevEKalivendiSJosephJKalyanaramanBActivation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxideBiochem J200236772974012139490
   PubMed Web of Science ®Google Scholar
• PastorinoFBrignoleCMarimpietriDVascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapyCancer Res2003637400740914612539
   PubMed Web of Science ®Google Scholar
• ZhangLYuDHicklinDJHannayJAEllisLMPollockRECombined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosisCancer Res2002622034204211929822
   PubMed Web of Science ®Google Scholar
• CaineGJStonelakePSLipGYKehoeSTThe hypercoagulable state of malignancy: pathogenesis and current debateNeoplasia2002446547312407439
   PubMed Web of Science ®Google Scholar
• UllahMFCancer multidrug resistance (MDR): a major impediment to effective chemotherapyAsian Pac J Cancer Prev200891618439063
   PubMed Web of Science ®Google Scholar
• SzakácsGPatersonJKLudwigJABooth-GentheCGottesmanMMTargeting multidrug resistance in cancerNat Rev Drug Discov2006521923416518375
   PubMed Web of Science ®Google Scholar
• KimDLeeESOhKTGaoZGBaeYHDoxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pHSmall200842043205018949788
   PubMed Web of Science ®Google Scholar
• ManzoorAALindnerLHLandonCDOvercoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumorsCancer Res2012725566557522952218
   PubMed Web of Science ®Google Scholar
• Kapse-MistrySGovenderTSrivastavaRYergeriMNanodrug delivery in reversing multidrug resistance in cancer cellsFront Pharmacol2014515925071577
   PubMed Web of Science ®Google Scholar
• RenYZhangHChenBMultifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistanceInt J Nanomedicine201272261226922619560
   PubMed Web of Science ®Google Scholar
• GaberMHModulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermiaJ Biochem Mol Biol Biophys2002630931412385965
   PubMedGoogle Scholar